Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Entacapone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | COMT known ✓ | P21964 | 5/20 | 1.00 |
| ▸ | FTO | Q9C0B1 | 8/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | ABCC3 | O15438 | 1/20 | 1.00 |
| ▸ | ABCC4 | O15439 | 1/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 1.00 |
| ▸ | EGFR | P00533 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | HPGD | P15428 | 1/20 | 0.60 |
| ▸ | RECQL | P46063 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Entacapone SCHEMBL3395296 | 1.00 | FTO (1.00) | FTOCOMTMEN1KMT2AABCC3 | |
| Entacapone SCHEMBL34505 | 1.00 | FTO (1.00) | FTOCOMTMEN1KMT2AABCC3 | |
| Entacapone SCHEMBL29356206 | 1.00 | FTO (1.00) | FTOCOMTMEN1KMT2AABCC3 | |
| Entacapone SCHEMBL34504 | 1.00 | FTO (1.00) | FTOCOMTMEN1KMT2AABCC3 | |
| Entacapone SCHEMBL29406523 | 1.00 | FTO (1.00) | FTOCOMTMEN1KMT2AABCC3 | |
| Entacapone SCHEMBL27766815 | 0.99 | FTO (0.98) | FTOCOMTMEN1KMT2AABCC3 | |
| Entacapone SCHEMBL4940150 | 0.98 | FTO (0.96) | FTOCOMTMEN1KMT2AABCC3 | |
| Entacapone SCHEMBL4940155 | 0.98 | FTO (0.96) | FTOCOMTMEN1KMT2AABCC3 | |
| Entacapone SCHEMBL26128138 | 0.97 | FTO (0.94) | FTOCOMTMEN1KMT2AABCC3 | |
| Entacapone SCHEMBL3972337 | 0.96 | FTO (0.92) | FTOCOMTMEN1KMT2AABCC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2046730-A1 | PROCESS AND PRODUCT | PLIVA HRVATSKA d.o.o. (HR) | 2009-04-15 | — | — | EP | claimed |
| WO-2008007093-A1 | PROCESS AND PRODUCT | PLIVA HRVATSKA D.O.O. (HR) | 2008-01-17 | — | — | WO | claimed |
| EP-1701937-A4 | STABLE POLYMORPHS OF (E)-N,N-DIETHYL-2-CYANO-3-(3,4-DIHYDROXY-5-NITROPHENYL)ACRYLAMIDE | WOCKHARDT LTD (IN) | 2007-05-02 | — | — | EP | claimed |
| EP-1701936-A4 | AN EFFICIENT PROCESS FOR THE MANUFACTURE OF (E)-ENTACAPONE POLYMORPHIC FORM A | WOCKHARDT LTD (IN) | 2007-01-24 | — | — | EP | claimed |
| US-20070004935-A1 | Efficient method for the manufacture of (E) -Entacapone polymorphic Form A | WOCKHARDT LIMITED | 2007-01-04 | — | — | US | claimed |
| EP-1701937-A1 | STABLE POLYMORPHS OF (E)-N,N-DIETHYL-2-CYANO-3-(3,4-DIHYDROXY-5-NITROPHENYL)ACRYLAMIDE | Wockhardt Limited (IN) | 2006-09-20 | — | — | EP | claimed |
| EP-1701936-A1 | AN EFFICIENT PROCESS FOR THE MANUFACTURE OF (E)-ENTACAPONE POLYMORPHIC FORM A | Wockhardt Limited (IN) | 2006-09-20 | — | — | EP | claimed |
| WO-2005070881-A1 | AN EFFICIENT PROCESS FOR THE MANUFACTURE OF (E)-ENTACAPONE POLYMORPHIC FORM A | WOCKHARDT LIMITED (IN) | 2005-08-04 | — | — | WO | claimed |
| WO-2005066117-A1 | STABLE POLYMORPHS OF (E)-N,N-DIETHYL-2-CYANO-3-(3,4-DIHYDROXY-5-NITROPHENYL)ACRYLAMIDE | WOCKHARDT LIMITED (IN) | 2005-07-21 | — | — | WO | claimed |
| WO-2014164667-A1 | DENGUE AND WEST NILE VIRUS PROTEASE INHIBITORS | GEORGETOWN UNIVERSITY (US) | 2014-10-09 | — | — | WO | disclosed |
| US-20090326062-A1 | PROCESS FOR PREPARING ENTACAPONE SUBSTANTIALLY FREE OF Z-ISOMER, SYNTHESIS INTERMEDIATES THEREOF AND A NEW CRYSTALLINE FORM | Chemo Iberica, SA (ES) | 2009-12-31 | — | — | US | disclosed |
| EP-1945607-B1 | A PROCESS FOR THE PREPARATION OF HIGHLY PURE (E) N,N-DIETHYL-2-CYANO-3-(3,4-DIHYDROXY- 5-NITRO PHENYL) ACRYLAMIDE (ENTACAPONE) | USV LTD (IN) | 2009-10-14 | — | — | EP | disclosed |
| EP-2046730-A1 | PROCESS AND PRODUCT | PLIVA HRVATSKA d.o.o. (HR) | 2009-04-15 | — | — | EP | disclosed |
| US-20080319226-A1 | Process For the Preparation of Highly Pure (E) N,N-Diethyl-2-Cyano-3-(3,4-Dihydroxy-5-Nitro Phenyl) Acrylamide (Entacapone) | USV LIMITED (IN) | 2008-12-25 | — | — | US | disclosed |
| WO-2007094007-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF ENTACAPONE | SUVEN LIFE SCIENCES LTD., (IN) | 2007-08-23 | — | — | WO | disclosed |
| WO-2007077572-A1 | A PROCESS FOR THE PREPARATION OF ENTACAPONE FORM-A | ACTAVIS GROUP PTC EHF (IS) | 2007-07-12 | — | — | WO | disclosed |
| WO-2007054950-A1 | A PROCESS FOR THE PREPARATION OF HIGHLY PURE (E) N,N-DIETHYL-2-CYANO-3-(3,4-DIHYDROXY- 5-NITRO PHENYL) ACRYLAMIDE (ENTACAPONE) | USV LIMITED (IN) | 2007-05-18 | — | — | WO | disclosed |
| US-20070060767-A1 | Methods for the preparation of Entacapone | SUVEN LIFE SCIENCES (IN) | 2007-03-15 | — | — | US | disclosed |
| US-20070060767-A1 | Methods for the preparation of Entacapone | SUVEN LIFE SCIENCES (IN) | 2007-03-15 | — | — | US | disclosed |
| WO-2005063693-A1 | IMPROVED PROCESS FOR THE PREPARATION OF ENTACAPONE | SUVEN LIFE SCIENCES LTD (IN) | 2005-07-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080319226-A1 | Process For the Preparation of Highly Pure (E) N,N-Diethyl-2-Cyano-3-(3,4-Dihydroxy-5-Nitro Phenyl) Acrylamide (Entacapone) | GNE, ADH1A, ADH5 | COMT 235/4885FTO 1781/4885MEN1 4625/4885 |
| US-20070060767-A1 | Methods for the preparation of Entacapone | OTC, NAAA, GNE | COMT 119/4885FTO 353/4885MEN1 1942/4885 |
| US-20070004935-A1 | Efficient method for the manufacture of (E) -Entacapone polymorphic Form A | COMT, GNE, GNMT | COMT 1/4885FTO 93/4885MEN1 3678/4885 |
| US-20090326062-A1 | PROCESS FOR PREPARING ENTACAPONE SUBSTANTIALLY FREE OF Z-ISOMER, SYNTHESIS INTERMEDIATES THEREOF AND A NEW CRYSTALLINE FORM | GNE, ENTPD5, ENTPD1 | COMT 452/4885FTO 1687/4885MEN1 2601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.